SEC 13F Intelligence

Checkpoint Capital L.P. / CYTK

Checkpoint Capital L.P.’s Cytokinetics Inc Position

Does Checkpoint Capital L.P. own Cytokinetics Inc (CYTK)? Yes — 180.0K shares worth $12M (+4.26% of its 13F portfolio) as of Q1 2026, up from 166.8K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
180.0K
% of Portfolio
+4.26%
Quarters Held
8
currently held

Position History CYTK

Reported value by quarter
Q4 ’23: $19MQ4 ’23Q1 ’24: $13MQ1 ’24Q2 ’24: $10MQ2 ’24Q3 ’24: $25MQ3 ’24Q4 ’24: $940,800Q4 ’24Q3 ’25: $2MQ3 ’25Q4 ’25: $11MQ4 ’25Q1 ’26: $12MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026180.0K$12M+4.26%
Q4 2025166.8K$11M+3.31%
Q3 202537.6K$2M+0.69%
Q4 202420.0K$940,800+0.48%
Q3 2024466.8K$25M+12.23%
Q2 2024190.0K$10M+6.21%
Q1 2024190.0K$13M+8.90%
Q4 2023230.0K$19M+11.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of CYTK.